We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.49B
Cap. Flow %
8.21%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.56%
2 Technology 14.21%
3 Consumer Discretionary 12.36%
4 Industrials 10.91%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MFIC icon
301
MidCap Financial Investment
MFIC
$781M
$14.1M 0.08%
830,817
+687,855
+481% +$12.3M
CA
302
DELISTED
CA, Inc.
CA
$14M 0.08%
421,898
-123,396
-23% -$4.1M
AIG icon
303
American International
AIG
$42.1B
$14M 0.08%
+235,351
New +$14.5M
BT
304
DELISTED
BT Group plc (ADR)
BT
$13.9M 0.08%
+763,814
New +$13.5M
GWPH
305
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$13.9M 0.08%
+105,250
New +$12.4M
LUV icon
306
Southwest Airlines
LUV
$23.9B
$13.9M 0.08%
212,190
-858,363
-80% -$50.5M
SITC icon
307
SITE Centers
SITC
$172M
$13.9M 0.08%
1,202,640
-279,772
-19% -$2.98M
MCO icon
308
Moody's
MCO
$83.8B
$13.8M 0.08%
93,493
-2,062
-2% -$302K
SRPT icon
309
Sarepta Therapeutics
SRPT
$1.68B
$13.6M 0.08%
244,721
-133,626
-35% -$7.08M
BFYT
310
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$13.6M 0.08%
544,301
+472,006
+653% +$10.6M
BMY icon
311
Bristol-Myers Squibb
BMY
$130B
$13.6M 0.07%
221,132
-861,196
-80% -$53.9M
TEN
312
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$13.5M 0.07%
230,394
+127,927
+125% +$7.56M
AGIO icon
313
Agios Pharmaceuticals
AGIO
$1.89B
$13.4M 0.07%
234,825
-3,556
-1% -$224K
EG icon
314
Everest Group
EG
$14.3B
$13.3M 0.07%
59,991
+22,656
+61% +$5.11M
CSII
315
DELISTED
Cardiovascular Systems, Inc.
CSII
$13.2M 0.07%
558,228
+2,563
+0.5% +$64.6K
XL
316
DELISTED
XL Group Ltd.
XL
$13.2M 0.07%
+374,874
New +$14.5M
WR
317
DELISTED
Westar Energy Inc
WR
$13.2M 0.07%
249,275
+863
+0.3% +$46.5K
VRNS icon
318
Varonis Systems
VRNS
$4.98B
$13M 0.07%
+806,154
New +$12.6M
EGIO
319
DELISTED
Edgio, Inc. Common Stock
EGIO
$13M 0.07%
+73,957
New +$14.6M
MSGN
320
DELISTED
MSG Networks Inc.
MSGN
$12.9M 0.07%
635,370
+592,634
+1,387% +$11.4M
TD icon
321
Toronto Dominion Bank
TD
$200B
$12.8M 0.07%
+218,100
New +$12.5M
MDLZ icon
322
Mondelez International
MDLZ
$79.9B
$12.8M 0.07%
299,063
-779,338
-72% -$32.7M
RIGL icon
323
Rigel Pharmaceuticals
RIGL
$756M
$12.7M 0.07%
328,088
+59,927
+22% +$2.28M
CSCO icon
324
Cisco
CSCO
$479B
$12.7M 0.07%
331,384
+297,641
+882% +$10.6M
HA
325
DELISTED
Hawaiian Holdings, Inc.
HA
$12.6M 0.07%
315,395
-231,658
-42% -$8.91M

Similar funds

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.